SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 9, 2026

TNXP

Tonix Pharmaceuticals Holding Corp.
BULLISH
Impact 4/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $117K total
Actionable Insight ▲ Bullish

The CEO's open-market purchase is a modest positive signal, but the tiny dollar amount relative to market cap limits its materiality. Monitor for any upcoming corporate events (pipeline catalysts, financing, or regulatory updates) that may have prompted the buying.

DirectionBullish
Confidencemedium
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
TNXP ▲ +21.99% at T+60d
LONG call ✓ call won +21.99% · α vs SPY +15.41% · entry $10.96 → $13.37
Entry = T+0 close
Jun 9, 2026
via day close
T+1d
-2.83%
call -2.83% · α -4.53%
$10.65
settled 5mo ago
T+5d
+6.11%
call +6.11% · α +2.68%
$11.63
settled 4mo ago
T+20d
+18.89%
call +18.89% · α +15.26%
$13.03
settled 4mo ago
T+60d
+21.99%
call +21.99% · α +15.41%
$13.37
settled 8w ago

Price Chart

Loading chart...

Executive Summary

CEO Seth Lederman and Director Richard Stillwell each purchased $59K and $58K worth of TNXP shares in open-market transactions on June 8-9, 2026. This insider buying cluster, though modest in absolute dollar value ($117K total, ~0.06% of market cap), is notable as it involves the CEO and a director making concurrent open-market purchases, which historically carries a stronger signal than non-cluster buys.

Key Financial Metrics

Direction
buying
Total Value
$117.2K
Insiders
2

Key Facts

  • CEO Seth Lederman purchased 5,000 shares at $11.79 for $58,950 on June 9, 2026.
  • Director Richard Stillwell purchased 5,000 shares at $11.65 for $58,250 on June 8, 2026.
  • Total cluster value: $117K, representing approximately 0.06% of TNXP's $187M market cap.
  • Both transactions were open-market purchases (code P), not grants or exercises.
  • No sales or other insider activity in the cluster window.

Financial Impact

Insider purchases totaling $117K, ~0.06% of market cap — economically trivial but directionally positive as a signal of insider conviction.

insider ownership

Risk Factors

  • Cluster value is only 0.06% of market cap — statistically noise-level, not a material insider signal.
  • No other context (earnings, press release, late filing) is provided to corroborate the insider buying.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TNXP-1781040640984
28 reports for TNXP
Performance horizon
63% Hit rate @ T+20 5 of 8 directional calls Went positive at some point 7 of 10 best @ T+20▲ +32.15%Aug 3, 2026
Filters
Rows
Reports for TNXP — sortable, filterable
TypeNow
Oct 19, 2026
7d ago
Press Release
NEUTRAL ★ 3/10
$5.73awaiting T+20—$5.30 (−7.50%)
Oct 15, 2026
11d ago
8-K
BULLISH ★ 5/10
$6.42awaiting T+20—$5.30 (−17.45%)
Oct 2, 2026
24d ago
8-K
BEARISH ★ 6/10
$8.07awaiting T+20—$5.30 (+34.32%)
Sep 22, 2026
4w ago
8-K
BULLISH ★ 5/10
$10.59 $5.78▼ −45.42%▼ −44.86%$5.30 (−49.95%)
Sep 8, 2026
6w ago
8-K
NEUTRAL ★ 2/10
$13.16 $7.70▼ −41.49%▼ −43.46%$5.30 (−59.73%)
Aug 10, 2026
11w ago
8-K
BULLISH ★ 6/10
$12.59 $13.16▲ +4.53%▲ +5.44%$5.30 (−57.90%)
Aug 10, 2026
11w ago
Press Release
MIXED ★ 6/10
$12.59 $13.16▲ +4.53%▲ +5.44%$5.30 (−57.90%)
Aug 3, 2026
12w ago
8-K
BULLISH ★ 6/10
$10.67 $14.10▲ +32.15%▲ +30.91%$5.30 (−50.33%)
Jul 27, 2026
13w ago
Press Release
NEUTRAL ★ 1/10
$10.37 $12.45▲ +20.06%▲ +16.76%$5.30 (−48.89%)
Jul 13, 2026
15w ago
8-K
BULLISH ★ 6/10
$11.71 $12.59▲ +7.56%▲ +4.38%$5.30 (−54.72%)
Showing 10 of 28

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 9, 2026